MTOR and neoplasm: If the global activation of the PI3K/AKT/mTOR signaling axis in the tumor epithelium and stroma compartment is validated in independent cohorts of samples, this assay may provide clinically useful information even from whole tissue samples without requiring additional cellular enrichment steps.